| pubmed-article:16173966 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16173966 | lifeskim:mentions | umls-concept:C0018957 | lld:lifeskim |
| pubmed-article:16173966 | lifeskim:mentions | umls-concept:C0027726 | lld:lifeskim |
| pubmed-article:16173966 | lifeskim:mentions | umls-concept:C0206153 | lld:lifeskim |
| pubmed-article:16173966 | lifeskim:mentions | umls-concept:C0009566 | lld:lifeskim |
| pubmed-article:16173966 | lifeskim:mentions | umls-concept:C1515895 | lld:lifeskim |
| pubmed-article:16173966 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:16173966 | pubmed:dateCreated | 2005-9-21 | lld:pubmed |
| pubmed-article:16173966 | pubmed:abstractText | Nephrotic syndrome (NS) is an extremely rare complication of myeloablative allogeneic haematopoietic cell transplantation (HCT) that usually occurs in association with chronic graft-versus-host disease (C-GVHD). We observed an unexpectedly high incidence of NS in a cohort of 163 consecutive patients undergoing non-myeloablative HCT from a related human leucocyte antigen-compatible donor. Seven patients developed NS at a median 318 d post-transplant (range 119-1203 d; cumulative incidence 6.1%). The median age at onset of NS was 46 years (range 33-59 years); three of the seven patients had no evidence of C-GVHD while four had accompanying limited C-GVHD. At diagnosis, median proteinuria was 16.5 g/24 h (range 3-24 g/24 h). Renal biopsy was performed in four cases and revealed membranous nephropathy. NS was not always associated with other symptoms of C-GVHD, and in contrast to previous reports, usually did not improve with the re-initiation of aggressive immunosuppression, resulting in progressive renal failure necessitating dialysis in three of seven cases. Membranous nephropathy resulting in NS is a previously unrecognised and clinically significant complication of non-myeloablative HCT. | lld:pubmed |
| pubmed-article:16173966 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16173966 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16173966 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16173966 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16173966 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16173966 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16173966 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16173966 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16173966 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16173966 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16173966 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:16173966 | pubmed:issn | 0007-1048 | lld:pubmed |
| pubmed-article:16173966 | pubmed:author | pubmed-author:TakahashiYY | lld:pubmed |
| pubmed-article:16173966 | pubmed:author | pubmed-author:IgarashiTT | lld:pubmed |
| pubmed-article:16173966 | pubmed:author | pubmed-author:BarrettJJ | lld:pubmed |
| pubmed-article:16173966 | pubmed:author | pubmed-author:ChildsRR | lld:pubmed |
| pubmed-article:16173966 | pubmed:author | pubmed-author:SrinivasanRR | lld:pubmed |
| pubmed-article:16173966 | pubmed:author | pubmed-author:BalowJ EJE | lld:pubmed |
| pubmed-article:16173966 | pubmed:author | pubmed-author:AustinHH | lld:pubmed |
| pubmed-article:16173966 | pubmed:author | pubmed-author:GellerNN | lld:pubmed |
| pubmed-article:16173966 | pubmed:author | pubmed-author:LundqvistAA | lld:pubmed |
| pubmed-article:16173966 | pubmed:author | pubmed-author:SabnisSS | lld:pubmed |
| pubmed-article:16173966 | pubmed:author | pubmed-author:TisdaleJJ | lld:pubmed |
| pubmed-article:16173966 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16173966 | pubmed:volume | 131 | lld:pubmed |
| pubmed-article:16173966 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16173966 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16173966 | pubmed:pagination | 74-9 | lld:pubmed |
| pubmed-article:16173966 | pubmed:dateRevised | 2007-4-30 | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:meshHeading | pubmed-meshheading:16173966... | lld:pubmed |
| pubmed-article:16173966 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16173966 | pubmed:articleTitle | Nephrotic syndrome: an under-recognised immune-mediated complication of non-myeloablative allogeneic haematopoietic cell transplantation. | lld:pubmed |
| pubmed-article:16173966 | pubmed:affiliation | Hematology Branch, National Heart, Lung and Blood Institute, Bethesda, MD 20892-1652, USA. | lld:pubmed |
| pubmed-article:16173966 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16173966 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16173966 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16173966 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16173966 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16173966 | lld:pubmed |
